Outlook: Heading towards 2020
Date: 15/10/2019
Venue: Level 3, The Strand at Coolangatta, 72-80 Marine Parade, Coolangatta , QLD, 4225
Provider: Outlook Eye Specialists
Contact: Lovella Stanford, [E] lovella.stanford@outlookeye.com.au, [P] 0755578888
Learning Objectives
- Understand the evidence and rationale for SLT as first line therapy for glaucoma.
- Be aware of ROCK inhibitors as the next class of glaucoma drops.
- Know the level of benefit of peripheral iridotomy in Primary Angle Closure Suspects (PACS) and Primary Angle Closure (PAC) patients.
- Know the implications of home genetic testing.
- Be aware of LUXTURNA gene therapy.
- Be able to review the role of genes in ocular disease.
- Have intimate knowledge of RAPD.
- Know the objective signs of optic nerve dysfunction.
- Understand ganglion cell anatomy from the retina to the chiasm.
- Know the relative contraindications of various IOL types and and refractive targets in patients with macular pathology.
- Understand the risk of retinal detachment, cystoid macular oedema, and other retinal complications in patients undergoing cataract surgery.
- Know which retinal/ ocular conditions increase the risk of postoperative cystoid macular oedema.
Max points awarded: 6.00
Session Information
| Name |
|---|
| An update on genes - the stuff that matters to the clinician |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Light, Zap, Eagle, Rock |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Retinal considerations in cataract surgery |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| A good optic nerve will do that - Part 2 |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |